New Paradigm of Lymphedema Management

A New Paradigm of Lymphedema Management

“Pre-operative assessment, prospective surveillance and early intervention may have prevented the onset of irreversible LE in this cohort of 43 patients.”^9,10

Physicians can now reduce the severity of lymphedema and its physiological and
psychological impact.

Patients can return to the quality of life they enjoyed prior to their breast cancer treatment knowing that their physician can clinically assess and treat the early signs of lymphedema.

Health insurance providers benefit from reduced costs and a preventative approach to an otherwise chronic, life-long condition with associated medical risks. Quality of life can be protected in these women.

Note: L-Dex™ values that lie outside the normal range may indicate the early signs of lymphedema and values that have changed +10 L-Dex units from baseline may also indicate early lymphedema. The L-Dex scale is a tool to assist in the clinical assessment of lymphedema by a medical provider. The L-Dex scale is not intended to diagnose or predict lymphedema of an extremity.